ZJ
Zegbeh Jallah Capital One Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Outlook Therapeutics
OTLK
$41.2M
| $0.9264 | $100 |
10,694%
upside
| Overweight |
27 Dec ‘23
1 year ago |
|
|
CBIO
2
Crescent Biopharma, Inc. Common Stock
CBIO
$180M
| $12.55 | $1,200 |
9,462%
upside
| Overweight |
22 Dec ‘23
1 year ago |
|
3
EyePoint Pharmaceuticals
EYPT
$941M
| $14.19 | $44 |
210%
upside
| Overweight |
11 Dec ‘23
1 year ago |
|
4
IDEAYA Biosciences
IDYA
$2.05B
| $24.74 | $29 |
17%
upside
| Overweight |
28 Dec ‘22
2 years ago |
|
5
RAPT Therapeutics
RAPT
$220M
| $13.60 | $384 |
2,724%
upside
| Overweight |
21 Sep ‘22
3 years ago |
|
6
Enanta Pharmaceuticals
ENTA
$190M
| $9.04 | $70 |
674%
upside
| Buy |
12 May ‘22
3 years ago |
|
|
ATYR
7
aTyr Pharma
ATYR
$520M
| $5.31 | $21 |
295%
upside
| Buy |
14 Sep ‘21
4 years ago |
|
8
Rezolute
RZLT
$703M
| $8.08 | $21 |
160%
upside
| Buy |
8 Sep ‘21
4 years ago |
|
9
Arvinas
ARVN
$583M
| $8 | $135 |
1,588%
upside
| Buy |
9 Aug ‘21
4 years ago |
|
10
Dare Bioscience
DARE
$29.1M
| $2.16 | $132 |
6,011%
upside
| Buy |
30 Jun ‘21
4 years ago |
|
11
Ocugen
OCGN
$322M
| $1.03 | $6 |
483%
upside
| Neutral |
11 Jun ‘21
4 years ago |
|
12
Kodiak Sciences
KOD
$517M
| $10.06 | $149 |
1,381%
upside
| Buy |
11 May ‘21
4 years ago |
|
13
KalVista Pharmaceuticals
KALV
$786M
| $15.61 | $55 |
252%
upside
| Buy |
18 Feb ‘21
4 years ago |
|
14
Clearside Biomedical
CLSD
$26.6M
| $0.3387 | $8 |
2,262%
upside
| Buy |
13 May ‘20
5 years ago |
|
|
15
RAPT Therapeutics
RAPT
$220M
| $13.60 | $304 |
2,135%
upside
| Buy |
13 Apr ‘20
5 years ago |
|
|
16
IDEAYA Biosciences
IDYA
$2.05B
| $24.74 | $12 |
52%
downside
| Buy |
13 Mar ‘20
5 years ago |
|